HOPA Virtual Practice Management Series
What if you could get practice management learning without leaving your practice for the day? Now you can! HOPA’s reimagined Virtual Practice Management (PM) Series will bring educational content and continuing education (CE) credits to you four times a year!
Our Virtual Practice Management Series:
- Provides single-topic, 60-90-minute webinars
- Makes live CE credits available more frequently
- Creates a consistent flow of timely practice management learning
- Removes travel, time off, and cost barriers of in-person learning
Designed to Keep Practice Managers, Managing Their Practice
We packed the same great content and speakers you have come to expect from HOPA’s Practice Management Program, but now in single-topic, 60-90-minute webinars. Attend from your home base and get bursts of learning about new protocols, best practices, and more!
Basically, it's all the practice management information and education you want, without the practice interruptions you don't!
Register for Webinar #1 here
"Operationalizing Bispecific Therapies: From Engaging T-cells to Care Teams"
- November 12, 2024, 1 p.m.-2:30 p.m. CT, via Zoom
- Cost: $25 for members, $33 for non-members
Learning objectives
- Describe significant efficacy and safety endpoints for bispecific T-cell engager therapies that are currently FDA-approved
- Propose strategies to enhance communication, coordination, and collaboration among healthcare systems, especially in transitions of care from inpatient to outpatient and community settings
- Develop guidelines for bispecific T-cell engager toxicity management and prevention
- Prepare education for dissemination to medical staff in the academic and community setting
- Illustrate potential strategies to mitigate financial challenges and unique operational requirements
- Employ patient selection criteria to optimize bispecific T-cell engager administration
Session description
Bispecific T-cell engagers are a new class of immunotherapeutics with efficacy in hematologic and solid malignancies. These agents share similar toxicities with other T-cell engaging therapies, including cytokine release syndrome and immune effector cell-associated neurotoxicity. With ever-increasing utilization of bispecific T-cell engagers, seeking collaboration across care settings – from community-based/rural clinical practices to academic medical centers – will be key. Optimization of bispecific T-cell engager administration requires a proactive approach across these teams to address transitions of care, prevention and management of reactions and other toxicities (including fine-tuning premedications), education of medical staff, financial and operational challenges (such as formulary management), and patient selection. This session aims to review updates associated with and provide tools to implement best practices for these considerations.
There will be 1.5 ACPE CE credits available for this first session.
Here are the six easy steps to claiming your credits:
Meet our speakers
Emilie Aschenbrenner, PharmD, BCOP
Emilie Aschenbrenner is an oncology board-certified clinical pharmacist and Hematology Coordinator for pharmacy at Froedtert and the Medical College of Wisconsin. She currently specializes in Bone Marrow Transplant and Cellular Therapy, and is involved in institutional quality improvement initiatives, guidelines, and FACT accreditation.
Grace Baek, PharmD, BCOP
Grace Baek is a Clinical Hematology/Oncology Pharmacist at Fred Hutchinson Cancer Center & UW Medicine in Seattle, Washington, and serves as a Clinical Instructor at the University School of Pharmacy. Baek specializes in hematology with an emphasis on lymphoid and plasma cell malignancies.
Megan May, PharmD, BCOP, FHOPA, FAPO
Megan May is a Clinical Oncology Pharmacy Specialist at Baptist Health Lexington's Cancer Center in Lexington, Kentucky. In addition to direct patient care, Dr. May plays an active role in the education of pharmacy students and residents. She has been involved at the national level with a number of professional organizations on various committees and positions over the years.
Anna Rivard, PharmD, BCOP
Anna Rivard is the lead oncology pharmacist at Billings Clinic Cancer Center in Billings, Montana. She is a current board member of the Oncology Pharmacy Network Pacific Northwest Chapter, and her areas of interest include immunotherapy, lymphomas, myeloma, leukemias, and practice management.
Click here to register for Webinar #1
Please join us for these upcoming webinars:
2025 Q1: March 4, 2025
- Topic and time to be determined
- Call for speakers is now closed
2025 Q2-Q4
- Topics and times to be determined
Want to be a Virtual Practice Management Speaker?
Are you well-versed in practice management but new to presenting live education? PM Virtual Webinars are a great place to get started as a subject matter expert! Please check our PM Speakers page for open calls.
Questions? Contact the HOPA Education team at education@hoparx.org.
Founding Sponsor
We would like to acknowledge Genentech as the Founding Sponsor of our 2024-2025 Virtual Practice Management Series. Thank you for your valued support!
